http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108586517-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6a6f422b091ba12ea61d4adbf1b0e8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f50ebe93b17d5ab34200decdb446e33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_756b70a986cc6665a092ddbd3dfac269
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-1892
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18
filingDate 2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ed084ad4bc6d83b7d54fe3f649a069c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_294af8b8e7ff53ddef052fde9b9753c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a9a6a69a4b542f4a74db88d05cb30b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbf4c6a4ad351db88553fd811e6857cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba78ce561612b4f39f933966ab1066fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31037b4a1ca5b2dd3cccd4ae011b002b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7905d2b756ea6273b1e9b7b87d53ba2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d46d9152ff3e728ab31069e9768c14a
publicationDate 2018-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108586517-A
titleOfInvention A kind of synthetic method of carbapenem antibiotic drug intermediate
abstract The invention discloses a synthesis method of a carbapenem antibiotic drug intermediate, using (R)-3-hydroxybutyrate as a raw material to prepare a carbapenem antibiotic drug intermediate 4‑AA, the route Raw materials are cheap and easy to get, and can be purchased in large quantities. The invention has simple steps, high yield of each step and simple reaction. The use of a chiral column to split a chiral center avoids the use of a noble metal chiral reduction catalyst, and the invention has the advantages of low cost, high yield and easy availability of reaction conditions.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111362889-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111362889-B
priorityDate 2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03246274-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467159849

Total number of triples: 24.